{
    "reg_info": {
        "full_title": "O. Reg. 583/20: LIVESTOCK MEDICINES",
        "reg_name_text": "LIVESTOCK MEDICINES",
        "citation": "O. Reg. 583/20: ",
        "act_under": "Animal Health Act, 2009",
        "url": "https://www.ontario.ca/laws/regulation/200583",
        "date_scraped": "2023-12-18 19:11:28"
    },
    "copyright": {
        "Copyright": "© King's Printer for Ontario, 2023."
    },
    "versions": [
        {
            "a_href": "/laws/about-e-laws#ccl",
            "valid_from": "January  1, 2021",
            "valid_to": "current"
        },
        {
            "a_href": "/laws/regulation/200583/v1",
            "valid_from": "October 19, 2020",
            "valid_to": "December 31, 2020"
        }
    ],
    "content": [
        {
            "id": "1.",
            "section": "Definition",
            "content": " 1. In this Regulation, “veterinary biologic” has the same meaning as in the Health of Animals Act (Canada).",
            "raw_html": "<p class=\"section-e\"> <b>1. </b>In this Regulation,</p> <p class=\"definition-e\">“veterinary biologic” has the same meaning as in the <i>Health of Animals Act</i> (Canada).</p>"
        },
        {
            "id": "2.",
            "section": "Livestock medicines",
            "content": " 2. (1) Subject to subsections (2), (3) and (4), the following drugs that are manufactured for use in livestock are prescribed as livestock medicines for the purposes of the definition of “livestock medicine” in section 2 of the Act: 1. Preparations for the control of external and internal parasites and insect pests. 2. Oral preparations for the prevention or treatment of disease of the digestive system, including bloat, colic, indigestion, diarrhea, constipation and impaction. 3. Preparations for the treatment of surface wounds and lacerations, wire cuts and burns. 4. Preparations for the treatment of skin diseases, including topical hoof care products. 5. Vitamins for injection or oral administration, including injectable vitamin A, not to exceed 500,000 International Units per millilitre, and injectable vitamin D, not to exceed 75,000 International Units per millilitre. 6. Preparations for the prevention or treatment of deficiencies, including hematinics for horses, containing, i. minerals for oral administration, ii. selenium for injection, or iii. iron for injection. 7. Propylene glycol and preparations, including dextrose, calcium, phosphorus and magnesium preparations, for the treatment and prevention of acetonemia and hypocalcemia or otherwise intended as an aid in the supportive treatment of nutritional deficiencies. 8. Implants and feed additives for use as growth promotants. 9. Anti-cannibalism compounds for use in poultry. 10. Topical preparations for use as liniments, counterirritants and poultices for the treatment of joint pain and swollen ligaments, tendons or muscles. 11. Oral or topical preparations for use as antitussives, decongestants, bronchodilators and expectorants. 12. Acetylsalicylic acid boluses for use in horses and cattle. 13. Disinfectants, udder washes, teat dips and sanitizers. 14. Antimicrobials, including their salts and derivatives. 15. A veterinary biologic that, i. was imported into Canada pursuant to a permit issued under section 121 of the  Health of Animals Regulations (Canada), or ii. was manufactured pursuant to a product licence issued under section 124 of the Health of Animals Regulations (Canada) and is permitted to be sold under those Regulations. (2) Any drug described in paragraphs 1 to 14 of subsection (1) is not prescribed as a livestock medicine for the purposes of the definition of “livestock medicine” in section 2 of the Act if it has not been assigned a drug identification number pursuant to subsection C.01.014.2 (1) of the Food and Drug Regulations (Canada). (3) A drug described in subsection (1) is not prescribed as a livestock medicine for the purposes of the definition of “livestock medicine” in section 2 of the Act if it is prescribed by subsection 3 (2) of Ontario Regulation 264/16 (General) made under the Drug and Pharmacies Regulation Act as being in Schedule I for the purposes of that Act. (4) The following veterinary biologics are not prescribed as livestock medicines for the purposes of the definition of “livestock medicine” in section 2 of the Act: 1. Anthrax vaccine. 2. Brucella vaccine. 3. Rabies vaccine. 4. Modified-live virus and live virus vaccines for use in mammals, except the following veterinary biologics: i. IBR-PI3 intranasal vaccine for cattle. ii. Mink distemper vaccine. iii. Mink enteritis vaccine.",
            "raw_html": "<p class=\"section-e\"> <b>2. </b>(1) Subject to subsections (2), (3) and (4), the following drugs that are manufactured for use in livestock are prescribed as livestock medicines for the purposes of the definition of “livestock medicine” in section 2 of the Act:</p> <p class=\"paragraph-e\">  1. Preparations for the control of external and internal parasites and insect pests.</p> <p class=\"paragraph-e\">  2. Oral preparations for the prevention or treatment of disease of the digestive system, including bloat, colic, indigestion, diarrhea, constipation and impaction.</p> <p class=\"paragraph-e\">  3. Preparations for the treatment of surface wounds and lacerations, wire cuts and burns.</p> <p class=\"paragraph-e\">  4. Preparations for the treatment of skin diseases, including topical hoof care products.</p> <p class=\"paragraph-e\">  5. Vitamins for injection or oral administration, including injectable vitamin A, not to exceed 500,000 International Units per millilitre, and injectable vitamin D, not to exceed 75,000 International Units per millilitre.</p> <p class=\"paragraph-e\">  6. Preparations for the prevention or treatment of deficiencies, including hematinics for horses, containing,</p> <p class=\"subpara-e\">  i. minerals for oral administration,</p> <p class=\"subpara-e\">  ii. selenium for injection, or</p> <p class=\"subpara-e\">  iii. iron for injection.</p> <p class=\"paragraph-e\">  7. Propylene glycol and preparations, including dextrose, calcium, phosphorus and magnesium preparations, for the treatment and prevention of acetonemia and hypocalcemia or otherwise intended as an aid in the supportive treatment of nutritional deficiencies.</p> <p class=\"paragraph-e\">  8. Implants and feed additives for use as growth promotants.</p> <p class=\"paragraph-e\">  9. Anti-cannibalism compounds for use in poultry.</p> <p class=\"paragraph-e\">  10. Topical preparations for use as liniments, counterirritants and poultices for the treatment of joint pain and swollen ligaments, tendons or muscles.</p> <p class=\"paragraph-e\">  11. Oral or topical preparations for use as antitussives, decongestants, bronchodilators and expectorants.</p> <p class=\"paragraph-e\">  12. Acetylsalicylic acid boluses for use in horses and cattle.</p> <p class=\"paragraph-e\">  13. Disinfectants, udder washes, teat dips and sanitizers.</p> <p class=\"paragraph-e\">  14. Antimicrobials, including their salts and derivatives.</p> <p class=\"paragraph-e\">  15. A veterinary biologic that,</p> <p class=\"subpara-e\">  i. was imported into Canada pursuant to a permit issued under section 121 of the <i> Health of Animals Regulations</i> (Canada), or</p> <p class=\"subpara-e\">  ii. was manufactured pursuant to a product licence issued under section 124 of the <i>Health of Animals Regulations</i> (Canada) and is permitted to be sold under those Regulations.</p> <p class=\"subsection-e\">  (2) Any drug described in paragraphs 1 to 14 of subsection (1) is not prescribed as a livestock medicine for the purposes of the definition of “livestock medicine” in section 2 of the Act if it has not been assigned a drug identification number pursuant to subsection C.01.014.2 (1) of the <i>Food and Drug Regulations</i> (Canada).</p> <p class=\"subsection-e\">  (3) A drug described in subsection (1) is not prescribed as a livestock medicine for the purposes of the definition of “livestock medicine” in section 2 of the Act if it is prescribed by subsection 3 (2) of Ontario Regulation 264/16 (General) made under the <i>Drug and Pharmacies Regulation Act</i> as being in Schedule I for the purposes of that Act.</p> <p class=\"subsection-e\">  (4) The following veterinary biologics are not prescribed as livestock medicines for the purposes of the definition of “livestock medicine” in section 2 of the Act:</p> <p class=\"paragraph-e\">  1. Anthrax vaccine.</p> <p class=\"paragraph-e\">  2. Brucella vaccine.</p> <p class=\"paragraph-e\">  3. Rabies vaccine.</p> <p class=\"paragraph-e\">  4. Modified-live virus and live virus vaccines for use in mammals, except the following veterinary biologics:</p> <p class=\"subpara-e\">  i. IBR-PI3 intranasal vaccine for cattle.</p> <p class=\"subpara-e\">  ii. Mink distemper vaccine.</p> <p class=\"subpara-e\">  iii. Mink enteritis vaccine.</p>"
        },
        {
            "id": "3.",
            "section": "Livestock medicines",
            "content": " 3. Omitted (provides for coming into force of provisions of this Regulation).",
            "raw_html": "<p class=\"section-e\"> <b>3.</b> <span class=\"ovsmallcap\">Omitted</span> (<span class=\"ovsmallcap\">provides for coming into force of provisions of this Regulation</span>).</p>"
        },
        {
            "id": null,
            "section": "Livestock medicines",
            "content": "  Français  ",
            "raw_html": "<p class=\"section-e\"> </p> <p class=\"MsoNormal\"><a href=\"http://www.ontario.ca/fr/lois/reglement/200583\">Français</a></p> <p class=\"MsoNormal\"> </p> <p class=\"MsoNormal\"></p>"
        }
    ]
}